Stay updated on Lymphodepletion & Anti-PD-1 to Reduce AML Relapse Clinical Trial
Sign up to get notified when there's something new on the Lymphodepletion & Anti-PD-1 to Reduce AML Relapse Clinical Trial page.

Latest updates to the Lymphodepletion & Anti-PD-1 to Reduce AML Relapse Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check26 days agoChange DetectedRevision updated to v3.4.3; the previous revision v3.4.2 was removed.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision: v3.4.2 has been added; older Revision: v3.4.1 and the government funding notice have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check61 days agoChange DetectedSite-wide maintenance notices were added regarding a lapse in government funding and NIH Clinical Center status, and the page revision tag updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check68 days agoChange DetectedGlossary display is now shown; metadata lines updated to 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0' replacing the previous lowercase variants and earlier revision.SummaryDifference0.2%

- Check83 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; no study content or data were altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Lymphodepletion & Anti-PD-1 to Reduce AML Relapse Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lymphodepletion & Anti-PD-1 to Reduce AML Relapse Clinical Trial page.